FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo
Novartis said Cosentyx, when used to treat active psoriatic arthritis, “narrowly missed statistical significance for superiority” versus Humira, a drug made by AbbVie.
Sounds like a pain in the neck 🥁🥁🌟
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novartis Trial of World’s Most Expensive Drug Halted Over Safety ConcernsNovartis has paused a clinical trial of its Zolgensma gene therapy after a separate study on animals raised concerns about side effects, dealing a setback to the company’s efforts to broaden the market for the world’s most expensive drug. The worlds most expensive drug, and now it's on hold? It was thrown all over social media as a wonder drug before, now it's not even making it to the shelves.
Source: WSJ - 🏆 98. / 63 Read more »